Zobrazeno 1 - 10
of 47
pro vyhledávání: '"D L Earnest"'
Publikováno v:
Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society. 21(11)
Increased cholinergic stimulation and accelerated gastrointestinal (GI) transit may be produced by direct stimulation of the acetylcholine (ACh) receptor with an appropriate agonist by increased release of ACh from cholinergic nerve terminals or by a
Autor:
G, Tougas, W J, Snape, M H, Otten, D L, Earnest, K-E, Langaker, R E, Pruitt, E, Pecher, B, Nault, M A, Rojavin
Publikováno v:
Alimentary pharmacologytherapeutics. 16(10)
Tegaserod is a 5-hydroxytryptamine-4 receptor partial agonist. Oral administration causes gastrointestinal effects resulting in increased gastrointestinal motility and attenuation of visceral sensation.: To determine the long-term safety and tolerabi
Autor:
R, Calaluce, D L, Earnest, D, Heddens, J G, Einspahr, D, Roe, C L, Bogert, J R, Marshall, D S, Alberts
Publikováno v:
Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 9(12)
Prostaglandin E2 (PGE2) has served as a surrogate end point biomarker in colorectal tumor progression. Colonic mucosa PGE2 levels of patients with colorectal adenomas or carcinomas have been shown to be higher than in control subjects. Our dose-findi
Autor:
H H, Chow, D L, Earnest, D, Clark, N, Mason-Liddil, C B, Kramer, J G, Einspahr, J M, Guillen-Rodriguez, D J, Roe, W, Malone, J A, Crowell, D S, Alberts
Publikováno v:
Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 9(4)
Nonsteroidal antiinflammatory drugs are among the most promising chemopreventive agents for colorectal cancer. Although the mechanism by which nonsteroidal antiinflammatory drugs exert such effects remains to be further characterized, their best know
Autor:
D S, Alberts, M E, Martínez, D J, Roe, J M, Guillén-Rodríguez, J R, Marshall, J B, van Leeuwen, M E, Reid, C, Ritenbaugh, P A, Vargas, A B, Bhattacharyya, D L, Earnest, R E, Sampliner
Publikováno v:
The New England journal of medicine. 342(16)
The risks of colorectal cancer and adenoma, the precursor lesion, are believed to be influenced by dietary factors. Epidemiologic evidence that cereal fiber protects against colorectal cancer is equivocal. We conducted a randomized trial to determine
Publikováno v:
Cancer research. 58(8)
We recently showed that feeding the cytoprotective bile acid ursodeoxycholic acid (UDCA) to rats resulted in significant reduction in polyps and especially cancers, both in number and size (D. L. Earnest et al., Cancer Res., 54: 5071-5074, 1994). Bec
Publikováno v:
The American journal of gastroenterology. 92(2)
Autor:
R K, Wali, B P, Frawley, S, Hartmann, H K, Roy, S, Khare, B A, Scaglione-Sewell, D L, Earnest, M D, Sitrin, T A, Brasitus, M, Bissonnette
Publikováno v:
Cancer research. 55(22)
Several lines of evidence from our laboratory and others indicate that epigenetic alterations in protein kinase C (PKC) are involved in colonic carcinogenesis in both man and experimental animals. Furthermore, bile salts, known activators of PKC, hav
Publikováno v:
Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 4(3)
It has been demonstrated and confirmed that certain nonsteroidal anti-inflammatory drugs which inhibit cyclooxygenase and the synthesis of prostaglandins and other eicosanoids, can reduce the formation of both colon polyps and cancers in experimental
Autor:
D L, Earnest, H, Holubec, R K, Wali, C S, Jolley, M, Bissonette, A K, Bhattacharyya, H, Roy, S, Khare, T A, Brasitus
Publikováno v:
Cancer research. 54(19)
The present studies were conducted at the Universities of Chicago and Arizona to examine and compare the effects of supplemental dietary ursodeoxycholic acid to cholic acid, a known tumor promoter, and to piroxicam, a known chemopreventive agent, in